The evolution of drug resistance in Mycobacterium tuberculosis:: From a mono-rifampin-resistant cluster into increasingly multidrug-resistant variants in an HIV-seropositive population
The evolution of drug resistance in Mycobacterium tuberculosis:: From a mono-rifampin-resistant cluster into increasingly multidrug-resistant variants in an HIV-seropositive population
复制标题
DOI:
10.1086/588822
复制
发表时间:
2008-07-01
影响因子:
6.4
通讯作者:
Kreiswirth, Barry N.
中科院分区:
文献类型:
--
作者:
Bifani, Pablo;Mathema, Barun;Kreiswirth, Barry N.
We describe the genotypic and phenotypic characteristics of a mono-rifampin-resistant (RIF(R)) Mycobacterium tuberculosis strain cluster (designated AU-RIF(R)) and the acquisition of additional drug resistance. Drug susceptibility, sequences of regions that determine drug resistance, and basic clinical data were examined. A rare codon duplication (514(TTC)) in rpoB conferring high levels of RIFR (minimum inhibitory concentration of > 256 mu g/mL) in 29 isolates was identified. AU-RIF(R) strains developed secondary resistance to isoniazid and 7 resistance combinations to 6 different antibiotics. Patients infected with AU-RIFR strains were primarily immunocompromised. These data suggest that host factors, such as HIV status, may allow dissemination of mono-RIF(R) strains and facilitate the accumulation of additional drug resistance.